Physician profile
Daniel W Griffin
NPI 1043481468
$30,336.98
in general payments reported to CMS, 2019-2025
9 companies · $96.21 in 2025
The $96.21 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $12K · 2021: $5,404 · 2022: $1,105 · 2023: $120 · 2024: $200 · 2025: $96.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29,737.56 | 2019-2023 | |
| Emd Serono, INC. | $161.10 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $160.15 | 2019-2025 | Menopur |
| Hologic Sales and Service, LLC | $146.00 | 2024 | Acessa Provu System |
| Pfizer INC. | $33.77 | 2023 | |
| Organon LLC | $33.01 | 2024 | |
| Novo Nordisk INC | $23.70 | 2025 | Wegovy |
| Sumitomo Pharma America, INC. | $21.72 | 2023 | Myfembree |
| Myovant Sciences INC. | $19.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.